Royal Bank of Canada’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.1M | Sell |
116,293
-40,680
| -26% | -$3.56M | ﹤0.01% | 1903 |
|
|
2025
Q4 | $13.3M | Buy |
156,973
+53,661
| +52% | +$4.28M | ﹤0.01% | 1757 |
|
|
2025
Q3 | $7.5M | Sell |
103,312
-12,875
| -11% | -$888K | ﹤0.01% | 2352 |
|
|
2025
Q2 | $7.62M | Buy |
116,187
+14,203
| +14% | +$925K | ﹤0.01% | 2241 |
|
|
2025
Q1 | $7.2M | Buy |
101,984
+325
| +0.3% | +$22.6K | ﹤0.01% | 1992 |
|
|
2024
Q4 | $6.68M | Buy |
101,659
+14,574
| +17% | +$1M | ﹤0.01% | 2108 |
|
|
2024
Q3 | $6.15M | Buy |
87,085
+1,342
| +2% | +$93.5K | ﹤0.01% | 2118 |
|
|
2024
Q2 | $5.69M | Sell |
85,743
-24,034
| -22% | -$1.57M | ﹤0.01% | 2080 |
|
|
2024
Q1 | $7.46M | Sell |
109,777
-9,350
| -8% | -$618K | ﹤0.01% | 1895 |
|
|
2023
Q4 | $7.36M | Buy |
119,127
+7,626
| +7% | +$448K | ﹤0.01% | 1959 |
|
|
2023
Q3 | $6.58M | Sell |
111,501
-16,905
| -13% | -$1.04M | ﹤0.01% | 1885 |
|
|
2023
Q2 | $7.67M | Sell |
128,406
-8,994
| -7% | -$535K | ﹤0.01% | 1778 |
|
|
2023
Q1 | $8.03M | Buy |
137,400
+7,497
| +6% | +$452K | ﹤0.01% | 1718 |
|
|
2022
Q4 | $8.06M | Sell |
129,903
-7,638
| -6% | -$459K | ﹤0.01% | 1774 |
|
|
2022
Q3 | $7.77M | Buy |
137,541
+14,178
| +11% | +$873K | ﹤0.01% | 1728 |
|
|
2022
Q2 | $7.88M | Sell |
123,363
-11,496
| -9% | -$730K | ﹤0.01% | 1732 |
|
|
2022
Q1 | $8.73M | Buy |
134,859
+7,485
| +6% | +$474K | ﹤0.01% | 1815 |
|
|
2021
Q4 | $8.47M | Buy |
127,374
+13,194
| +12% | +$837K | ﹤0.01% | 2007 |
|
|
2021
Q3 | $6.97M | Sell |
114,180
-37,356
| -25% | -$2.37M | ﹤0.01% | 2071 |
|
|
2021
Q2 | $9.38M | Buy |
151,536
+3,543
| +2% | +$215K | ﹤0.01% | 1854 |
|
|
2021
Q1 | $8.76M | Buy |
147,993
+27,861
| +23% | +$1.68M | ﹤0.01% | 1844 |
|
|
2020
Q4 | $7.18M | Buy |
120,132
+33,897
| +39% | +$1.93M | ﹤0.01% | 1942 |
|
|
2020
Q3 | $4.7M | Sell |
86,235
-95,586
| -53% | -$5.15M | ﹤0.01% | 2050 |
|
|
2020
Q2 | $9.33M | Buy |
181,821
+103,095
| +131% | +$5.18M | ﹤0.01% | 1529 |
|
|
2020
Q1 | $3.53M | Sell |
78,726
-65,328
| -45% | -$3.29M | ﹤0.01% | 2052 |
|
|
2019
Q4 | $7.69M | Sell |
144,054
-58,656
| -29% | -$2.89M | ﹤0.01% | 1817 |
|
|
2019
Q3 | $9.45M | Buy |
202,710
+72,417
| +56% | +$3.47M | ﹤0.01% | 1613 |
|
|
2019
Q2 | $6.55M | Sell |
130,293
-4,185
| -3% | -$207K | ﹤0.01% | 1881 |
|
|
2019
Q1 | $6.9M | Buy |
134,478
+49,809
| +59% | +$2.48M | ﹤0.01% | 1776 |
|
|
2018
Q4 | $3.97M | Buy |
84,669
+9,219
| +12% | +$473K | ﹤0.01% | 2158 |
|
|
2018
Q3 | $4.22M | Sell |
75,450
-58,860
| -44% | -$3.22M | ﹤0.01% | 2242 |
|
|
2018
Q2 | $6.78M | Sell |
134,310
-23,463
| -15% | -$1.16M | ﹤0.01% | 1803 |
|
|
2018
Q1 | $7.76M | Sell |
157,773
-25,425
| -14% | -$1.31M | ﹤0.01% | 1706 |
|
|
2017
Q4 | $9.43M | Buy |
183,198
+100,959
| +123% | +$5.19M | ﹤0.01% | 1651 |
|
|
2017
Q3 | $4.29M | Buy |
82,239
+2,952
| +4% | +$152K | ﹤0.01% | 2098 |
|
|
2017
Q2 | $4.1M | Sell |
79,287
-45,993
| -37% | -$2.32M | ﹤0.01% | 2084 |
|
|
2017
Q1 | $6.3M | Sell |
125,280
-54,228
| -30% | -$2.68M | ﹤0.01% | 1765 |
|
|
2016
Q4 | $8.46M | Buy |
179,508
+58,779
| +49% | +$2.79M | ﹤0.01% | 1619 |
|
|
2016
Q3 | $6.01M | Sell |
120,729
-31,989
| -21% | -$1.62M | ﹤0.01% | 1795 |
|
|
2016
Q2 | $7.35M | Sell |
152,718
-52,911
| -26% | -$2.52M | ﹤0.01% | 1651 |
|
|
2016
Q1 | $9.39M | Sell |
205,629
-143,115
| -41% | -$6.7M | 0.01% | 1418 |
|
|
2015
Q4 | $18.8M | Buy |
348,744
+60,267
| +21% | +$3.17M | 0.01% | 1014 |
|
|
2015
Q3 | $14.2M | Sell |
288,477
-49,215
| -15% | -$2.82M | 0.01% | 963 |
|
|
2015
Q2 | $19.7M | Buy |
337,692
+63,972
| +23% | +$3.74M | 0.01% | 824 |
|
|
2015
Q1 | $15.7M | Buy |
273,720
+51,054
| +23% | +$2.79M | 0.01% | 968 |
|
|
2014
Q4 | $11.2M | Buy |
222,666
+17,814
| +9% | +$868K | 0.01% | 1152 |
|
|
2014
Q3 | $9.58M | Sell |
204,852
-12,156
| -6% | -$549K | 0.01% | 1229 |
|
|
2014
Q2 | $9.77M | Buy |
217,008
+150
| +0.1% | +$6.45K | 0.01% | 1237 |
|
|
2014
Q1 | $9.16M | Buy |
216,858
+6,717
| +3% | +$282K | 0.01% | 1209 |
|
|
2013
Q4 | $8.27M | Sell |
210,141
-2,259
| -1% | -$84.7K | 0.01% | 1313 |
|
|
2013
Q3 | $7.53M | Buy |
212,400
+1,626
| +0.8% | +$57.3K | 0.01% | 1292 |
|
|
2013
Q2 | $7M | Buy |
+210,774
| New | +$7M | 0.01% | 1238 |
|
Other funds holding IHE
FIA
ACA
MSCM
ACM
IWS
Royal Bank of Canada's IHE Position: Q1 2026 in Review
Royal Bank of Canada reduced its iShares US Pharmaceuticals ETF (IHE) stake by 26% in Q1 2026, selling an estimated $3.56M and leaving 116,293 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1903.
Royal Bank of Canada first reported a position in IHE in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.7M in Q2 2015. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.
- Royal Bank of Canada held 116,293 shares of iShares US Pharmaceuticals ETF worth $10.1M as of Q1 2026.
- Royal Bank of Canada sold 40,680 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $3.56M.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1903 holding.
- Royal Bank of Canada first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's iShares US Pharmaceuticals ETF position peaked at $19.7M in Q2 2015.
- 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.